Pharming Group Financials

Pharming Group Stock Summary

Pharming Group competes with IGG, and Sino Biopharmaceutica. Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. Pharming Grp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 277 people.

Pharming Group Key Financial Ratios

There are many critical financial ratios that Pharming Group's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Pharming Group NV reports annually and quarterly.

Pharming Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pharming Group's current stock value. Our valuation model uses many indicators to compare Pharming Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharming Group competition to find correlations between indicators driving Pharming Group's intrinsic value. More Info.Pharming Group NV is regarded second in return on equity category among its peers. It is considered to be number one stock in return on asset category among its peers reporting about  0.39  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Pharming Group NV is roughly  2.60 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharming Group's earnings, one of the primary drivers of an investment's value.

Pharming Group NV Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Pharming Group help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharming Group NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharming Group NV based on widely used predictive technical indicators. In general, we focus on analyzing Pharming Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharming Group's daily price indicators and compare them against related drivers.

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.